Personalized prevention for couples

夫妻个性化预防

基本信息

  • 批准号:
    10664980
  • 负责人:
  • 金额:
    $ 49.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

1 SUMMARY / ABSTRACT 2 3 Between one to two-thirds of new HIV infections among MSM are attributable to sex with main partners (i.e., 4 male couples).1,2 48% of HIV-positive MSM in 5 US cities who were HIV tested in CDC's NHBS project were 5 unaware of their status,3 suggesting the potential for high levels of unknown sero-discordance among male 6 couples. Research has also illustrated the role that relationship dynamics (e.g., HIV-specific social support, 7 constructive communication, sexual agreements) have in shaping male couples' risk for HIV4-41; this has also 8 been shown longitudinally, strongly suggesting that promoting positive relationship dynamics is a significant 9 intervention point for reducing HIV transmission among male couples.42-44 There is also evidence at-risk male 10 couples can work together towards shared HIV prevention and care-related goals, including PrEP and U=U/TasP 11 that rely on adherence and resultant viral suppression, leading to increased health and reduced likelihood of 12 onward HIV transmission.45-55 Innovative and tailored solutions are needed to meet the HIV prevention and care 13 needs of at-risk male couples. Our solution is to leverage our strong findings from the preliminary work we 14 conducted in the US (R34 pilot RCT & mixed method acceptability project)59-62 to propose a highly novel, 5-year 15 project to revise and update an existing, eHealth couples-based HIV/STI prevention toolkit intervention that 16 showed promise for reducing couples' HIV risk. The intervention is theoretically grounded in Couples 17 Interdependence Theory for health behavior change.63,64 We will first apply the remaining stages of the ADAPT- 18 ITT model65 with elements of human-centered design66-69 to incorporate at-risk, sero-concordant negative and 19 sero-discordant male couples' prevention and relationship needs while also including the latest science in 20 HIV/STI prevention. We will then conduct a 16-month RCT with 300 at-risk male couples using a delayed, 21 educational control condition of 8 months. Our Specific Aims are to: 1) examine efficacy of the intervention on 22 couples' a) formation and adherence to a risk-reduction plan and agreement, b) relationship functioning, c) self- 23 reported and biomarker confirmed indicators of risk (sexual behavior and STI), and engagement in HIV 24 prevention (PrEP adherence) and care (ART adherence); 2) evaluate use of the intervention over time by using 25 three different data sources; 3) explore moderating and mediating effects on couples' outcomes a-c. Our proposal 26 has high Public Health significance given the HIV disparities and importance of attending to couples' unique 27 relationship and prevention needs. Our innovative, accessible, and tailored intervention will fill a gap in current 28 prevention services by offering couples a personalized program. We believe results from the fully powered RCT 29 will show efficacy toward improving sustained HIV prevention outcomes among at-risk male couples in the US. 30 The scientific premise and rigor will further allow us to understand the processes that couples work together 31 to manage HIV/STIs in their relationships. Our next steps may include conducting a Type 1 Hybrid Trial to assess 32 for effectiveness and explore best practices for future implementation.70
1概要/摘要 2 3在男男性行为者中,三分之一至三分之二的新艾滋病毒感染可归因于与主要伴侣的性行为(即, 4对男性夫妇)。1,2在CDC的NHBS项目中接受HIV检测的5个美国城市中,48%的HIV阳性MSM是 5例不知道自己的状况,3例提示男性中存在高水平未知血清不一致的可能性 六对夫妇。研究还说明了关系动态(例如,针对艾滋病毒的社会支助, 7建设性的沟通,性协议)在塑造男性夫妇的艾滋病毒风险4 -41;这也 8纵向显示,强烈表明促进积极的关系动态是一个重要的 减少男性配偶之间艾滋病毒传播的9个干预点42 -44 10对夫妇可以共同努力实现艾滋病毒预防和护理相关的目标,包括PrEP和U=U/TasP 11依赖于坚持和由此产生的病毒抑制,导致增加健康和减少的可能性, 45 -55需要有创新的、量身定制的解决方案,以满足艾滋病毒预防和护理的需求。 有风险的男性伴侣的13种需求。我们的解决方案是利用我们从初步工作中得出的强有力的发现, 14在美国进行(R34试点RCT和混合方法可接受性项目)59-62,以提出一种高度新颖的5年期 15个项目,修订和更新现有的基于电子保健夫妇的艾滋病毒/性传播感染预防工具包干预措施, 16项研究显示,有希望降低夫妇感染艾滋病毒的风险。这种干预在理论上是以夫妇为基础的。 17健康行为改变的相互依赖理论。63,64我们将首先应用适应性调整的其余阶段, 18 ITT模型65,具有以人为中心的设计元素66 -69,以纳入有风险、血清一致性阴性和 19对血清不一致的男性夫妇的预防和关系需求,同时也包括最新的科学, 20预防艾滋病毒/性传播感染。然后,我们将对300对高危男性夫妇进行为期16个月的随机对照试验, 21例8个月的教育对照情况。我们的具体目标是:1)检查干预的有效性, 22对夫妇的a)形成和遵守风险降低计划和协议,B)关系运作,c)自我 23个报告的和生物标志物证实的风险指标(性行为和性传播感染),以及艾滋病毒感染情况 24预防(PrEP依从性)和护理(ART依从性); 2)通过使用 25三种不同的数据来源; 3)探索对夫妇结果的调节和中介作用a-c。我们的建议 26具有很高的公共卫生意义,因为艾滋病毒的差异和照顾夫妇独特的重要性, 27、预防和控制的需要。我们创新的、可获得的和量身定制的干预措施将填补当前 28预防服务,为夫妇提供个性化的计划。我们认为,全功率RCT的结果 29将显示对改善美国高危男性夫妇的持续艾滋病毒预防结果的有效性。 30科学的前提和严谨性将进一步让我们了解夫妻共同工作的过程 31人在其关系中管理艾滋病毒/性传播感染。我们的下一步可能包括进行1型混合试验, 32以提高效率,并探讨今后实施的最佳做法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason W Mitchell其他文献

Jason W Mitchell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason W Mitchell', 18)}}的其他基金

Heterosexual couples' attitudes and associated factors of couple's HIV testing and counseling
异性恋夫妇对HIV检测和咨询的态度及影响因素
  • 批准号:
    10371551
  • 财政年份:
    2021
  • 资助金额:
    $ 49.67万
  • 项目类别:
Personalized prevention for couples
夫妻个性化预防
  • 批准号:
    10442571
  • 财政年份:
    2021
  • 资助金额:
    $ 49.67万
  • 项目类别:
Acceptability, feasibility, and preliminary impact of a web-based, HIV prevention toolkit with cisgender male couples in Lima, Peru
秘鲁利马顺性别男性夫妇基于网络的艾滋病毒预防工具包的可接受性、可行性和初步影响
  • 批准号:
    10442648
  • 财政年份:
    2021
  • 资助金额:
    $ 49.67万
  • 项目类别:
Personalized prevention for couples
夫妻个性化预防
  • 批准号:
    10321460
  • 财政年份:
    2021
  • 资助金额:
    $ 49.67万
  • 项目类别:
Acceptability, feasibility, and preliminary impact of a web-based, HIV prevention toolkit with cisgender male couples in Lima, Peru
秘鲁利马顺性别男性夫妇基于网络的艾滋病毒预防工具包的可接受性、可行性和初步影响
  • 批准号:
    10327025
  • 财政年份:
    2021
  • 资助金额:
    $ 49.67万
  • 项目类别:
Acceptability of a patient-centered decision aid to inform HIV prevention choices and uptake among at-risk male couples
以患者为中心的决策援助的可接受性,以告知高危男性夫妇的艾滋病毒预防选择和接受情况
  • 批准号:
    10362142
  • 财政年份:
    2021
  • 资助金额:
    $ 49.67万
  • 项目类别:
Understanding the effects of substance use on male couples risk for HIV
了解物质使用对男性夫妇感染艾滋病毒风险的影响
  • 批准号:
    10372367
  • 财政年份:
    2021
  • 资助金额:
    $ 49.67万
  • 项目类别:
Acceptability, feasibility, and preliminary impact of a web-based, HIV prevention toolkit with cisgender male couples in Lima, Peru
秘鲁利马顺性别男性夫妇基于网络的艾滋病毒预防工具包的可接受性、可行性和初步影响
  • 批准号:
    10633222
  • 财政年份:
    2021
  • 资助金额:
    $ 49.67万
  • 项目类别:
Understanding the effects of substance use on male couples' risk for HIV
了解物质使用对男性夫妇感染艾滋病毒风险的影响
  • 批准号:
    9439398
  • 财政年份:
    2016
  • 资助金额:
    $ 49.67万
  • 项目类别:
Understanding the effects of substance use on male couples' risk for HIV
了解物质使用对男性夫妇感染艾滋病毒风险的影响
  • 批准号:
    9528407
  • 财政年份:
    2016
  • 资助金额:
    $ 49.67万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 49.67万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了